EUROGIN Roadmaps

EUROGIN Roadmaps are aimed at updating the highest standards in HPV related cancer by translating evidence-based data into clinical practice.
The rapidly increasing volume and complexity of medical progress in the field makes it difficult for physicians to incorporate data into daily practice.
EUROGIN Roadmaps are designed as a tool to assist physicians in the decision making process, and hence improve quality of care. The process of developing guidelines includes needs' assessment, defining and evaluating implementation options. Revision is complex and requires a great deal of expertise and experience. This collection of peer reviewed papers provided by a broad group of international and independent experts is an exciting piece of work of the scientific evidence in this field.

Eurogin Roadmap 2017:
Triage strategies for the management of HPV-positive women in cervical screening programs
(Int J Cancer. 2018 Jan 17)

Eurogin Roadmap 2016:
How HPV knowledge is changing screening practice
(Int J Cancer. 2017 © 2016 UICC)

Eurogin Roadmap 2015:
How has HPV knowledge changed our practice: Vaccines
Brotherton JM1,2, Jit M3,4, Gravitt PE5, Brisson M6, Kreimer AR7, Pai SI8, Fakhry C9, Monsonego J10, Franceschi S11 Int J Cancer. 2016 Aug 1;139(3):510-7

EUROGIN 2014 roadmap:
Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection
( Int J Cancer. 2014 Jul 17. © 2014 UICC)

EUROGIN 2012 roadmap
on Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
(Int. J. Cancer: 134, 497–507 - 2014). © 2013 UICC)

EUROGIN 2011 roadmap
on prevention and treatment of HPV-related disease
(Arbyn M, de Sanjosé S, Saraiya M, et al. Int J Cancer 2012, in press)

EUROGIN 2010 roadmap
on cervical cancer prevention
(Int. J. Cancer: 128, 2765–2774 (2011) © 2011 UICC)

EUROGIN 2008 roadmap
on cervical cancer prevention
(Int. J. Cancer: 2009. © 2009 UICC)

EUROGIN 2007 roadmap
on cervical cancer prevention
(Vaccine. 2008 Mar 14;26 Suppl 1:A1-3)

Patient Education Conference Report
Part 1
(Vaccine 2007, 11.075)

Patient Education Conference Report
Part 2
(Vaccine. 2008 Mar 14;26 Suppl 1:A33-A36.)

Recommendations guidelines
(Gynecologic Oncology 103, 2006, 7)

Recommendations guidelines
(Gynecol Oncol. 2005 Mar;96(3):830-9.)

Recommendations guidelineswbr> (Int. J. Cancer: 108, 329–333, 2004)